Multi-language transfer learning for low-resource legal case summarization

Analyzing and evaluating legal case reports are labor-intensive tasks for judges and lawyers, who usually base their decisions on report abstracts, legal principles, and commonsense reasoning. Thus, summarizing legal documents is time-consuming and requires excellent human expertise. Moreover, public legal corpora of specific languages are almost unavailable. This paper proposes a transfer learning approach with extractive and abstractive techniques to cope with the lack of labeled legal summarization datasets, namely a low-resource scenario. In particular, we conducted extensive multi- and cross-language experiments. The proposed work outperforms the state-of-the-art results of extractive summarization on the Australian Legal Case Reports dataset and sets a new baseline for abstractive summarization. Finally, syntactic and semantic metrics assessments have been carried out to evaluate the accuracy and the factual consistency of the machine-generated legal summaries

EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part VI - Ultrasound-guided vascular interventions

The sixth part of the Guidelines on Interventional Ultrasound produced under the auspices of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) assesses the evidence for ultrasound guidance and assistance in vascular interventions. Based on convincing data, real-time sonographic guidance for central venous access is strongly recommended as a key safety measure. Systematic analysis of scientific literature shows that in difficult situations and special circumstances US guidance may also improve the efficacy and safety of peripheral venous and arterial access and endovascular interventions. Moreover, the recommendations of this guideline endorse the use of ultrasound to detect complications of vascular access and US-guided interventional treatment of arterial pseudoaneurysms.publishersversionPeer reviewe

Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis

Background: Due to its poor survival, intrahepatic cholangiocarcinoma (ICC) is held to be a much more aggressive cancer than hepatocellular carcinoma (HCC). In most published series, patients were diagnosed when symptomatic. However, ICC is now increasingly being discovered during the surveillance for HCC in cirrhosis. Whether this earlier detection of ICC is associated with an equally dismal prognosis or not is unknown. Methods: This is amulticenter retrospective study of consecutive ICC patients. Patients were stratified into subgroups according to the absence/presence of cirrhosis. A propensity score matching was performed to reduce the potential biases. Cirrhotic patients were further stratified according to their surveillance status. The lead-time bias and its potential effects were also estimated. Results: We gathered 184 patients. Eighty-five patients (46.2%) were cirrhotic. Liver cirrhosis was not related to a worse overall survival (33.0 vs. 32.0 months, p = 0.800) even after the propensity score analysis (43.0 in vs. 44.0 months in 54 pairs of patients, p = 0.878). Among the cirrhotic population, 47 (55.3%) patients had received a diagnosis of ICC during a surveillance programme. The 2 subgroups differed in maximum tumour dimensions (30 vs. 48 mm in surveyed and non-surveyed patients, respectively). Surveyed patients were more likely to receive surgical treatments (59.8 vs. 28.9%, p = 0.003). Overall survival was higher in surveyed patients (51.0 vs. 21.0 months, p 0.001). These benefits were confirmed after correcting for the lead-time bias. Conclusions: Cirrhotic patients have different clinical presentation and outcomes of ICC according to their surveillance status. In our series, ICC in cirrhosis was not associated with worse OS. Cirrhosis itself should not discourage either surgical or non-surgical treatments

Treatment of hepatocellular carcinoma with immune checkpoint inhibitors and applicability of first-line atezolizumab/bevacizumab in a real-life setting

Immune checkpoint inhibitors (ICIs) are the new frontier for the treatment of advanced hepatocellular carcinoma (HCC). Since the first trial with tremelimumab, a cytotoxic T-lymphocyte-associated protein 4 inhibitor, increasing evidence has confirmed that these drugs can significantly extend the survival of patients with advanced hepatocellular carcinoma (HCC). As a matter of fact, the overall survival and objective response rates reported in patients with advanced HCC treated with ICIs are the highest ever reported in the second-line setting and, most recently, the combination of the anti-programmed death ligand protein-1 atezolizumab with bevacizumab—an anti-vascular endothelial growth factor monoclonal antibody—demonstrated superiority to sorafenib in a Phase III randomized clinical trial. Therefore, this regimen has been approved in several countries as first-line treatment for advanced HCC and is soon expected to be widely used in clinical practice. However, despite the promising results of trials exploring ICIs alone or in combination with other agents, there are still some critical issues to deal with to optimize the prognosis of advanced HCC patients. For instance, the actual proportion of patients who are deemed eligible for ICIs in the real-life ranges from 10% to 20% in the first-line setting, and is even lower in the second-line scenario. Moreover, long-term data regarding the safety of ICIs in the population of patients with cirrhosis and impaired liver function are lacking. Lastly, no biomarkers have been identified to predict response, and thus to help clinicians to individually tailor treatment. This review aimed to summarize the state of the art immunotherapy in HCC and, by analyzing a large, multicenter cohort of Italian patients with HCC, to assess the potential applicability of the combination of atezolizumab/bevacizumab in the real-life setting

Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease

Background: The intestinal stem cells (ISC) modulation and the role of circulating hematopoietic stem cells (HSC) in coeliac disease (CD) are poorly understood. Our aim was to investigate the longitudinal modifications in peripheral blood HSC traffic and putative ISC density induced by gluten-free diet (GFD) in CD. Methods: Thirty-one CD patients and 7 controls were enrolled. Circulating CD133+ and CD34+ HSC were measured by flow cytometry, at enrolment and after 7 days and 1, 3, 6, 12, and 24 months of GFD. Endoscopy was performed at diagnosis and repeated at 6, 12, and 24 months following GFD. We used the Marsh-Oberhuber score to evaluate the histological severity of duodenal damage; immunohistochemistry was employed to measure the intraepithelial lymphoid infiltrate (IEL, CD3+ lymphoid cells) and the putative ISC compartment (CD133+ and Lgr5+ epithelial cells). Results: At enrolment, circulating HSCs were significantly increased in CD patients and they further augmented during the first week of GFD, but progressively decreased afterwards. CD patients presented with villous atrophy, abundant IEL and rare ISC residing at the crypt base. Upon GFD, IEL progressively decreased, while ISC density increased, peaking at 12 months. After 24 months of GFD, all patients were asymptomatic and their duodenal mucosa was macroscopically and histologically normal. Conclusions: In active CD patients, the ISC niche is depleted and there is an increased traffic of circulating HSC versus non-coeliac subjects. GFD induces a precocious mobilization of circulating HSC, which is followed by the expansion of the local ISC compartment, leading to mucosal healing and clinical remission

EFSUMB Statement on Medical Student Education in Ultrasound [long version]

Publisher Copyright: © 2016 Georg Thieme Verlag. All rights reserved.The European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) recommends that ultrasound should be used systematically as an easy accessible and instructive educational tool in the curriculum of modern medical schools. Medical students should acquire theoretical knowledge of the modality and hands-on training should be implemented and adhere to evidence-based principles. In this paper we report EFSUMB policy statements on medical student education in ultrasound that in a short version is already published in Ultraschall in der Medizin 1.publishersversionPeer reviewe

Derivation of the method of characteristics for the fluid dynamic solution of flow advection along porous wall channels

This paper describes in detail a novel formulation of the method of characteristics for its application to solve one-dimensional compressible unsteady non-homentropic flow advected along porous wall channels. In particular, the method is implemented into a wall-flow monolith Diesel particulate filter model whose purpose is the pressure drop prediction. The flow inside the monolith channels is considered to be one-dimensional and the flow through the porous wall treated as a source term agree with the Darcy's law. The flow dynamic behaviour at internal nodes of the channels is solved by means of shock capturing methods, whereas the end nodes, or boundary conditions, are solved applying the method of characteristics. The derived solution in this study of the Riemann variables and the entropy level includes the variation along the space-time plane due to cross-section area changes, friction and heat transfer as traditionally stated, but also takes into account the key influence on every line of the flow leaving or entering to the channels through the porous walls. © 2011 Elsevier Inc.Desantes Fernández, JM.; Serrano Cruz, JR.; Arnau Martínez, FJ.; Piqueras Cabrera, P. (2012). Derivation of the method of characteristics for the fluid dynamic solution of flow advection along porous wall channels. Applied Mathematical Modelling. 36:3134-3152. doi:10.1016/j.apm.2011.09.090S313431523

Experimental theoretical methodology for determination of inertial pressure drop distribution and pore structure properties in wall-flow diesel particulate filters (DPFs)

Wall-flow particulate filters have been placed as a standard technology for Diesel engines because of the increasing restrictions to soot emissions. The inclusion of this system within the exhaust line requires the development of computational tools to properly simulate its flow dynamics and acoustics behaviour. These aspects become the key to understand the influence on engine performance and driveability as a function of the filter placement. Since the pressure drop and the filtration process are strongly depending on the pore structure properties - permeability, porosity and pore size - a reliable definition of these characteristics is essential for model development. In this work a methodology is proposed to determine such properties based on the combination of the pressure drop rement in a steady flow test rig and two theoretical approaches. The later are a lumped model and a one-dimensional (1D) unsteady compressible flow model. The purpose is to simplify the integration of particulate filters into the global engine modelling and development processes avoiding the need to resort to specific and expensive characterisation tests. The proposed methodology was validated against measurements of the response of an uncoated diesel particulate filter (DPF) under different flow conditions as cold steady flow, impulsive flow and hot pulsating flow. © 2011 Elsevier Ltd.This work has been partially supported by the Spanish Ministerio de Ciencia e Innovacion through grant number DPI2010-20891-C02-02.Payri González, F.; Broatch Jacobi, JA.; Serrano Cruz, JR.; Piqueras Cabrera, P. (2011). Experimental theoretical methodology for determination of inertial pressure drop distribution and pore structure properties in wall-flow diesel particulate filters (DPFs). Energy. 36(12):6731-6744. https://doi.org/10.1016/j.energy.2011.10.033S67316744361

EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part III - Abdominal Treatment Procedures (Short Version)

Publisher Copyright: © Georg Thieme Verlag KG Stuttgart · New York ·.The third part of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines on Interventional Ultrasound assesses the evidence for ultrasound-guided and assisted interventions in abdominal treatment procedures. Recommendations for clinical practice are presented covering indications, contraindications, safety and efficacy of the broad variety of these techniques. In particular, drainage of abscesses and fluid collections, interventional tumor ablation techniques, interventional treatment of symptomatic cysts and echinococcosis, percutaneous transhepatic cholangiography and drainage, percutaneous gastrostomy, urinary bladder drainage, and nephrostomy are addressed (short version; a long version is published online).publishersversionPeer reviewe